No Prescription |
 |
 | ||
|
Emla cream Generic Lidocaine |
|
| ||
No Prescription » Prescription Drugs 7 » Emla cream Generic Lidocaine Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Emla cream contains two active ingredients lidocaine (previously known as lignocaine in the UK) and prilocaine. These are both a type of medicine called a local anaesthetic. They are used to numb areas that would otherwise feel pain. Pain is caused by the stimulation of pain receptors at the ends of nerves. The stimulation causes sodium to enter the nerve ending which causes an electrical signal to build up in the nerve. When this electrical signal is big enough it passes along the nerve to the brain where the signal is interpreted as pain. Lidocaine and prilocaine work by temporarily blocking this pathway of pain signals along nerves. They do this by stopping the sodium entering the nerve ending at the site of the pain. This prevents an electrical signal building up and passing along the nerve fibres to the brain. When Emla cream is applied to the skin the lidocaine and prilocaine prevent pain signals passing from that area to the brain and so numb the skin. This means otherwise painful procedures can be performed without causing pain. The cream can be used to temporarily numb the surface of the skin before procedures such as injections taking blood samples and minor skin surgery. The cream is applied in a thick layer underneath a dressing for at least one hour (at least two hours for procedures on large areas eg split skin grafting) and up to five hours before the procedure. Your doctor pharmacist or nurse will either apply the cream or show you how much to use and where to apply it. This will depend on the procedure that will be performed. The dressing is removed just before the medical procedure starts. You can get dressings to use with the cream from your pharmacist or doctor. Under the supervision of a medical professional the cream may also be used to temporarily numb the genitals in adults before the removal of genital warts (no dressings required for this use). The cream is applied five to ten minutes before this procedure starts. What is it used for? Temporarily numbing the surface of the skin before potentially painful procedures such as injections taking blood and minor skin surgery. Temporarily numbing the genitals in adults before the removal of genital warts (only under the supervision of a medical professional). Buy Emla cream Generic Lidocaine and other Prescription Drugs 7 products online at Medstore. 4961
About Emla cream Generic Lidocaine: Product Type: Prescription Drugs 7 Emla cream ( Generic Lidocaine/Prilocaine ) Emla cream (Generic Lidocaine/Prilocaine) Generic Lidocaine/Prilocaine 25/25mg/g 5 x 5gm Tubes Generic Lidocaine/Prilocaine Emla cream
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
